查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1209786

全球移植市场：到 2028 年的预测——按产品、应用、最终用户和地区分析

Transplantation Market Forecasts to 2028 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

全球移植市场在 2022 年将达到 138 亿美元，预计到 2028 年将达到 264 亿美元，在预测期内以 11.4% 的复合年增长率增长，据 Stratistics MRC 我预计.

移植是将器官或组织从一个身体移植到另一个身体的外科手术。 移植通常在发生器官衰竭时进行。 器官衰竭通常由多种因素引起，包括严重创伤、失血、中毒、药物滥用、白血病、败血症和其他急性疾病。 在心臟、肾臟、肝臟、肺、胰腺、肠、胸腺和子宫等器官上进行移植。 肾功能衰竭和狼疮等慢性病的增加需要紧急器官更换，导致移植增加。

器官采购和移植网络（OPTN）的初步数据显示，美国已经进行了42,000例器官移植，增长了5.9%，等待器官移植的患者有1,22915人。。

市场动态

驱动程序

对 3D 生物打印的需求不断增长

器官捐献者的持续短缺和等待器官移植的患者数量不断增加增加了对 3D 生物打印的需求。 这些技术用于创建定制的假体、製造组织并支持合成模型的植入。 3D 生物打印技术的引入增加了全球器官移植手术的数量，导致移植市场的增长。

抑製剂

器官移植费用高

器官移植是一个积累高额费用的大过程，因为所有移植的器官都必须经过一系列的评估、匹配、筛选和等待程序，然后才能用于移植手术。 此外，通常很难获得器官和进行移植手术。 它还包括患者的住院费用，因为他们将在移植前住院。 最困难的部分是获得廉价的器官捐献者。 这阻碍了市场的增长。

机会

移植技术的进步

随着移植技术的进步和製造商新产品的推出，肾臟、肝臟、心臟、肺和组织移植的数量正在增加。 这导致移植中心和医疗保健中心的数量增加。 改进的医疗基础设施、专业外科医生的可用性以及具有卓越技术的先进产品正在推动市场的增长。

威胁

漫长的等待时间

由于器官稀缺，器官移植等待时间很长。 越来越需要这样的程序来有效地照顾危重病人。 器官捐赠者必须准备好捐赠器官，但器官必须满足所有要求并准备好移植。 找到完美的捐赠者可能需要数月甚至数年的时间。 结果，它有时会导致患者死亡，从而阻碍了市场的增长。

COVID-19 的影响

Covid 大流行并没有扰乱医疗保健行业，但它导致全球器官移植登记量下降。 移植和器官捐献手术数量的下降主要是由于资源、值班外科医生、封锁和旅行限制等不可用因素造成的。 由于可能感染，报告 COVID-19 呈阳性的患者避免了器官捐献。 COVID-19 疗法和免疫抑製剂之间的相互作用已导致移植物捐献者出现大量器官衰竭，这引起了人们的极大关注。

预计在预测期内纸巾产品部分将是最大的部分

由于新产品的开发，卫生纸产品部门预计将实现有利增长。 用于组织器官移植的主要产品是组织製品、免疫抑製剂和保存液。 用于组织癒合、恢復正常功能和减轻疼痛的骨科手术有所增加。 人工耳蜗、心臟瓣膜、骨髓、骨科软组织等植入手术数量的增加以及世界人口老龄化正在促进这一细分市场的增长。

预计免疫抑製剂部分在预测期内的复合年增长率最高。

免疫抑製剂部分预计在预测期内将呈现最快的复合年增长率增长，因为它具有降低人体排斥移植器官能力等优势。 由于自身免疫性疾病如斑秃、多发性硬化症、关节炎和肾、肺、肝和心臟等器官衰竭的发病率不断增加，这些药物被大量使用。

市场份额最高的地区

由于用于治疗的创新植入式产品的持续开发，预计北美在预测期内将占据最大的市场份额。 该地区拥有发达的医疗系统。 该地区的人们显着增加了个人健康支出。 各种大型生物技术和医疗设备公司的存在，以及政府的支持政策，预计将提振该地区的收益。

复合年增长率最高的地区

由于慢性病和交通事故的增加，预计亚太地区在预测期内的复合年增长率最高。 各种慢性病的高患病率和交通事故的增加对器官造成永久性损伤，需要用健康器官替换受损器官以挽救患者的生命。 该地区主要参与者在移植技术方面的持续进步表明市场正在稳步增长。

主要发展

2022 年 3 月，Zimmer Biomet 与 Biocomposites 签订了一项多年期协议，在美国独家商业化具有新混合系统和交付选项的 Genex 骨移植替代品。

2022 年 1 月，诺华开始与 Alnylam 联合研究用于恢復肝功能的靶向治疗药物。 Alnylam 的 Sirna 技术旨在促进功能性肝细胞再生，是肝功能衰竭患者的替代疗法。

本报告的内容

  • 按地区和国家细分的市场细分
  • 向新进入者提出战略建议
  • 2020、2021、2022、2025 和 2028 年的综合市场数据
  • 市场趋势（驱动因素、制约因素、机会、威胁、挑战、投资机会、建议）
  • 根据市场预测在关键业务领域提出战略建议
  • 竞争格局映射主要共同趋势
  • 公司简介，包括详细的战略、财务状况和近期发展
  • 映射最新技术进步的供应链趋势

免费定制服务

订阅此报告的客户将免费获得以下自定义选项之一。

  • 公司简介
    • 其他市场参与者的综合概况（最多 3 家公司）
    • 主要参与者的 SWOT 分析（最多 3 家公司）
  • 区域细分
    • 根据客户要求对主要国家/地区的市场进行估算、预测和復合年增长率（注意：基于可行性检查。）
  • 竞争基准
    • 根据产品组合、地域分布和战略联盟对主要参与者进行基准测试

内容

第 1 章执行摘要

第2章前言

  • 概览
  • 利益相关者
  • 调查范围
  • 调查方法
    • 数据挖掘
    • 数据分析
    • 数据验证
    • 研究方法
  • 调查来源
    • 主要研究信息来源
    • 二手研究资源
    • 假设

第3章市场趋势分析

  • 司机
  • 约束因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第 5 章全球移植市场：按产品分类

  • 保存解决方案
  • 纸巾产品
  • 免疫抑製剂
  • 其他产品

第 6 章全球移植市场：按应用

  • 组织移植
  • 器官移植
  • 其他应用

第 7 章。全球移植市场：按最终用户分类

  • 移植中心
  • 医院
  • 其他最终用户

第 8 章全球移植市场：区域

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 意大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 新西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 卡塔尔
    • 南非
    • 其他中东地区

第9章主要进展

  • 合同、伙伴关係、协作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第10章公司简介

  • Novartis AG
  • 21 st Century Medicine
  • Stryker Corporation
  • TransMedics
  • Zimmer Biomet
  • Astellas Pharma Inc
  • Medtronic
  • AbbVie Inc
  • Biolife Solutions
  • Teva Pharmaceutical
  • Veloxis Pharmaceuticals Inc
  • Abbott
  • Becton, Dickinson and Company（BD）
  • BioMerieux SA
  • Bio-Rad Laboratories Inc
  • CareDx Inc
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc
  • Illumina Inc
  • QIAGEN
  • Arthrex Inc
Product Code: SMRC22208

According to Stratistics MRC, the Global Transplantation Market is accounted for $13.8 billion in 2022 and is expected to reach $26.4 billion by 2028 growing at a CAGR of 11.4% during the forecast period. Transplantation is a surgical procedure of implanting an organ or tissue from one body to another body. It is usually done when there is an organ failure. Organ failure generally occurs due to various factors such as serious trauma, loss of blood, poisoning, drug abuse, leukaemia, sepsis and other acute diseases. Transplantation was done to organs like heart, kidneys, liver, lungs, pancreas, intestine, thymus and uterus. Increase in chronic diseases such as kidney failure and lupus needs immediate change of organs which led to rise in transplantation.

According to the preliminary data from the Organ Procurement and Transplantation Network (OPTN), 42,000 organ transplants were performed in U.S with an increase of 5.9% and 1,22,915 patients are waiting to receive organs for transplant.

Market Dynamics:

Driver:

Increasing demand of 3D bioprinting

The continuous shortage of organ donors and the increasing number of patients on the waiting list for organ transplants have increased the demand for 3D bioprinting. These techniques are used to create customized prosthetics, fabricate tissue, and to support transplantation through synthetic models. The introduction of 3D bioprinting techniques has led to the growth of the transplantation market by driving the number of organ transplant procedures globally.

Restraint:

High cost for transplantation

Organ transplantation accumulates high cost due to its large process because every transplant organ must go through a series of evaluation, matching, screening and waiting procedures before it can be used in the transplant surgery. It is often difficult for patients to secure organs and transplant surgeries. The costs include the patient's hospitalization as they stay before transplant also. Acquisition of organ donor for lesser prices is the most difficult aspect. This reason hampers the market growth.

Opportunity:

Advancement in transplantation technology

Advancement in transplantation technology and the launch of new products by manufacturers has raised the number of transplant procedures including kidney, liver, heart, lungs and tissues. This increased the number of transplant centers and healthcare centers. Well-developed healthcare infrastructure and availability of expert surgeons & advanced products with better technology has propelled the growth of the market.

Threat:

Extensive wait time

Organ transplantation takes extensive wait time due to the fewer organ donations. There is an increased need for these procedures to care for the critically patient population effectively. Even the donor is ready to donate the organ; the organ should match all the requisites and should be fully fledgeble to be transplanted. To get a perfect donor, it will almost take few months and can also be extended for too many years. This can sometimes even cause death of the patient and thus it hinders the growth of the market.

COVID-19 Impact

The covid pandemic did not hit the healthcare industry into disarray but caused a drop in organ transplant surgery enrolment worldwide. The decrease in the number of transplantation and organ donation procedures is mainly because of factors such as unavailability of resources, engaged surgeons, lockdown and travel restrictions. Patients with positive reports for COVID-19 were refrained from donating organs due to the possibility of infection. The immunosuppressant drug interactions with COVID-19 therapy agents, had led to a significant number of organ failures from graft donors which became the major concern.

The tissue products segment is expected to be the largest during the forecast period

The tissue products segment is estimated to have a lucrative growth, due to its new product development. Major products used for tissue or organ transplantation are tissue products, immune suppressants and preservation solutions. It has raised the orthopedic procedures for tissue healing, normal functioning restoration and pain minimization. The increasing number of transplantation procedures such as that of cochlear, heart valves, bone marrow and orthopedic soft tissues and the rising geriatric population across the globe is attributed to the growth of the segment.

The immunosuppressive drugs segment is expected to have the highest CAGR during the forecast period

The immunosuppressive drugs segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the benefits this drug offers such as lowering the body ability to reject a transplanted organ. These drugs are highly used for auto immune disorders, such as alopecia areata, multiple sclerosis and arthritis, combined with the rising incidence of organ failures, especially the kidneys, lungs, liver, and heart.

Region with highest share:

North America is projected to hold the largest market share during the forecast period owing to their continuous development of innovative transplantation products for treatment. This region has well-developed healthcare system. The population here are increasing expenditure on personal health drastically. Strong presence of various large-scale biotechnology and medical device companies and presence of supportive government policies is expected to drive revenue growth of this region.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the increase in chronic diseases and road accidents. High prevalence of various chronic diseases and increasing incidence of road accidents are causing permanent damage to the organs resulting in replacement of damaged organs with healthy organs in order to save patient's life. Continuous advancements in transplantation technology by major players in this region are registering the steady growth in the market.

Key players in the market

Some of the key players profiled in the Transplantation Market include Novartis AG, 21st Century Medicine, Stryker Corporation, TransMedics, Zimmer Biomet, Astellas Pharma Inc, Medtronic, AbbVie Inc, Biolife Solutions, Teva Pharmaceutical, Veloxis Pharmaceuticals Inc, Abbott, Becton, Dickinson and Company (BD), BioMerieux SA, Bio-Rad Laboratories Inc, CareDx Inc, F. Hoffmann-La Roche Ltd, Hologic Inc, Illumina Inc, QIAGEN and Arthrex Inc.

Key Developments:

In March 2022, Zimmer Biomet entered into a multiyear agreement with Bio composites to exclusively distribute Genex Bone Graft Substitute with its new mixing system and delivery options in the U.S.

In January 2022, Novartis AG collaborated with Alnylam intending to explore targeted therapy to restore liver function. Alnylam's Sirna technology is intended to promote the regrowth of functional liver cells and is an alternative for liver failure patients.

Products Covered:

  • Preservation Solutions
  • Tissue Products
  • Immunosuppressive Drugs
  • Other Products

Applications Covered:

  • Tissue Transplant
  • Organ Transplant
  • Other Applications

End Users Covered:

  • Transplantation Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transplantation Market, By Product

  • 5.1 Introduction
  • 5.2 Preservation Solutions
  • 5.3 Tissue Products
  • 5.4 Immunosuppressive Drugs
  • 5.5 Other Products

6 Global Transplantation Market, By Application

  • 6.1 Introduction
  • 6.2 Tissue Transplant
  • 6.3 Organ Transplant
  • 6.4 Other Applications

7 Global Transplantation Market, By End User

  • 7.1 Introduction
  • 7.2 Transplantation Centers
  • 7.3 Hospitals
  • 7.4 Other End Users

8 Global Transplantation Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Novartis AG
  • 10.2 21 st Century Medicine
  • 10.3 Stryker Corporation
  • 10.4 TransMedics
  • 10.5 Zimmer Biomet
  • 10.6 Astellas Pharma Inc
  • 10.7 Medtronic
  • 10.8 AbbVie Inc
  • 10.9 Biolife Solutions
  • 10.10 Teva Pharmaceutical
  • 10.11 Veloxis Pharmaceuticals Inc
  • 10.12 Abbott
  • 10.13 Becton, Dickinson and Company (BD)
  • 10.14 BioMerieux SA
  • 10.15 Bio-Rad Laboratories Inc
  • 10.16 CareDx Inc
  • 10.17 F. Hoffmann-La Roche Ltd
  • 10.18 Hologic Inc
  • 10.19 Illumina Inc
  • 10.20 QIAGEN
  • 10.21 Arthrex Inc

List of Tables

  • Table 1 Global Transplantation Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Transplantation Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
  • Table 4 Global Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
  • Table 5 Global Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
  • Table 6 Global Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 7 Global Transplantation Market Outlook, By Application (2020-2028) ($MN)
  • Table 8 Global Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
  • Table 9 Global Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
  • Table 10 Global Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 11 Global Transplantation Market Outlook, By End User (2020-2028) ($MN)
  • Table 12 Global Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
  • Table 13 Global Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 14 Global Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 15 North America Transplantation Market Outlook, By Country (2020-2028) ($MN)
  • Table 16 North America Transplantation Market Outlook, By Product (2020-2028) ($MN)
  • Table 17 North America Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
  • Table 18 North America Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
  • Table 19 North America Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
  • Table 20 North America Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 21 North America Transplantation Market Outlook, By Application (2020-2028) ($MN)
  • Table 22 North America Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
  • Table 23 North America Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
  • Table 24 North America Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 25 North America Transplantation Market Outlook, By End User (2020-2028) ($MN)
  • Table 26 North America Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
  • Table 27 North America Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 28 North America Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 29 Europe Transplantation Market Outlook, By Country (2020-2028) ($MN)
  • Table 30 Europe Transplantation Market Outlook, By Product (2020-2028) ($MN)
  • Table 31 Europe Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
  • Table 32 Europe Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
  • Table 33 Europe Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
  • Table 34 Europe Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 35 Europe Transplantation Market Outlook, By Application (2020-2028) ($MN)
  • Table 36 Europe Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
  • Table 37 Europe Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
  • Table 38 Europe Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 39 Europe Transplantation Market Outlook, By End User (2020-2028) ($MN)
  • Table 40 Europe Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
  • Table 41 Europe Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 42 Europe Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 43 Asia Pacific Transplantation Market Outlook, By Country (2020-2028) ($MN)
  • Table 44 Asia Pacific Transplantation Market Outlook, By Product (2020-2028) ($MN)
  • Table 45 Asia Pacific Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
  • Table 46 Asia Pacific Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
  • Table 47 Asia Pacific Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
  • Table 48 Asia Pacific Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 49 Asia Pacific Transplantation Market Outlook, By Application (2020-2028) ($MN)
  • Table 50 Asia Pacific Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
  • Table 51 Asia Pacific Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
  • Table 52 Asia Pacific Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 53 Asia Pacific Transplantation Market Outlook, By End User (2020-2028) ($MN)
  • Table 54 Asia Pacific Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
  • Table 55 Asia Pacific Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 56 Asia Pacific Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 57 South America Transplantation Market Outlook, By Country (2020-2028) ($MN)
  • Table 58 South America Transplantation Market Outlook, By Product (2020-2028) ($MN)
  • Table 59 South America Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
  • Table 60 South America Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
  • Table 61 South America Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
  • Table 62 South America Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 63 South America Transplantation Market Outlook, By Application (2020-2028) ($MN)
  • Table 64 South America Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
  • Table 65 South America Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
  • Table 66 South America Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 67 South America Transplantation Market Outlook, By End User (2020-2028) ($MN)
  • Table 68 South America Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
  • Table 69 South America Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 70 South America Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 71 Middle East & Africa Transplantation Market Outlook, By Country (2020-2028) ($MN)
  • Table 72 Middle East & Africa Transplantation Market Outlook, By Product (2020-2028) ($MN)
  • Table 73 Middle East & Africa Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
  • Table 74 Middle East & Africa Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
  • Table 75 Middle East & Africa Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
  • Table 76 Middle East & Africa Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 77 Middle East & Africa Transplantation Market Outlook, By Application (2020-2028) ($MN)
  • Table 78 Middle East & Africa Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
  • Table 79 Middle East & Africa Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
  • Table 80 Middle East & Africa Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 81 Middle East & Africa Transplantation Market Outlook, By End User (2020-2028) ($MN)
  • Table 82 Middle East & Africa Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
  • Table 83 Middle East & Africa Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 84 Middle East & Africa Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)